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Summary
Homeostasis in theDrosophilamidgut ismaintained by stem
cells [1, 2]. The intestinal epithelium contains two types of
differentiated cells that are lost and replenished: enteroen-
docrine (EE) cells and enterocytes (ECs). Intestinal stem
cells (ISCs) are the only cells in the adult midgut that pro-
liferate [3, 4], and ISC divisions give rise to an ISC and an
enteroblast (EB), which differentiates into an EC or an EE
cell [3–5]. If the midgut epithelium is damaged, then ISC pro-
liferation increases [6–12]. Damaged ECs express secreted
ligands (Unpaired proteins) that activate Jak-Stat signaling
in ISCs and EBs to promote their proliferation and differenti-
ation [7, 9, 13, 14]. We show that the Hippo pathway com-
ponents Warts and Yorkie mediate a transition from low- to
high-level ISC proliferation to facilitate regeneration. The
Hippo pathway regulates growth in diverse organisms and
has been linked to cancer [15, 16]. Yorkie is activated in
ECs in response to tissue damage or activation of the
damage-sensing Jnk pathway. Activation of Yorkie pro-
motes expression of unpaired genes and triggers a nonau-
tonomous increase in ISC proliferation. Our observations
uncover a role for Hippo pathway components in regulating
stem cell proliferation and intestinal regeneration.
Results and Discussion
Yorkie (Yki) is negatively regulated by the Warts (Wts) kinase,
which promotes its cytoplasmic localization [17–21]. To inves-
tigate potential roles for theHippo pathway in the development
or physiology of the intestine, we analyzed the consequences
of Yki activation. Yki was activated by either mutation or RNA
interference (RNAi)-mediated depletion of wts, or else by
expression of an activated form of Yki (YkiS168A:V5) [22], which
contains a mutation in a key Wts phosphorylation site. To
restrict Yki activation to adult stages, we made use of the
TARGET system [23], in which a gene or RNAi line of interest
is expressed under UAS-Gal4 control, and then tight temporal
control is provided by simultaneous expression of a tempera-
ture-sensitive transcriptional repressor of Gal4-driven expres-
sion (Gal80ts).
In initial experiments, endogenous Yki was activated
throughout the adult fly by using a wts hairpin transgene (wts
RNAi) expressed under tub-Gal4 control to deplete endoge-
nous Wts. This resulted in a pronounced hyperplasia of the
intestine, with many tightly packed cells, and a thicker intes-
tinal epithelium (Figures 1B and 1C; see also Figures S1A–*Correspondence: irvine@waksman.rutgers.eduS1C available online). This was accompanied by an apparent
increase in intestinal stem cell (ISC) proliferation, as revealed
by staining for expression of the Notch ligand Delta (Dl)
(Figure 1C; Figure S1C). Normally, Dl is specifically expressed
in ISCs within the intestine and is lost from the enteroblast (EB)
daughter cell when ISCs divide [5]. However, toxins, infection,
or Jnk pathway activation can substantially increase numbers
of Dl-expressing cells [6, 8, 9, 11, 12], apparently because the
loss of Dl expression in EBs is slow compared to the increased
proliferation rate of ISCs. The intestinal hyperplasia and
increased number of Dl-expressing cells imply that Hippo
signaling normally functions to limit cell numbers in the intes-
tine, at least in part by keeping ISC proliferation at a low level.
To confirm the role of Wts and Yki in ISC proliferation and to
identify the cell types inwhich they function, we employed cell-
type-specific Gal4 drivers. As markers of progenitor cells, we
used both Dl and escargot (esg), which is expressed specifi-
cally in ISCs and EBs [3]. Surprisingly, when YkiS168A:V5 was
expressed in the ISC and EB under esg-Gal4 control (Fig-
ure S1M), no effect on intestinal morphology or progenitor
cell numbers was detected, even 10 days after induction of
YkiS168A:V5 expression (Figure 1D). Thus, Yki activation in
ISCs does not affect their proliferation. Visceral muscle cells
adjacent to the intestinal epithelium have been reported to
promote ISC proliferation by expressing Wingless [24]. To
examine whether Yki acts in muscle cells to promote ISC pro-
liferation, we expressed YkiS168A:V5 using How-Gal4, which
drives expression in muscles [25] (Figures S1G and S1H).
Although a patchy increase in progenitor cells was detected
at longer time points (10 days after induction; Figure S1F),
hardly any effect was observed at shorter time points (3 days
after induction of YkiS168A:V5; Figure S1E).
By contrast to the relatively modest or undetectable con-
sequences of Yki activation in muscles or ISCs, Yki activation
in the differentiated enterocytes (ECs) of the intestinal epithe-
lium resulted in a rapid and dramatic hypertrophy (Figure 1).
YkiS168A:V5 was expressed specifically in ECs using Myo-Ia-
Gal4 [9] (Figures S1I–S1L). The resulting intestinal overgrowth
was associated with multiple layers of intestinal cells (Fig-
ure 1H), by contrast to the normal monolayer (Figure 1G).
Moreover, the intestinal lumen filled with cells (Figure 1H),
presumably sloughed off from the overproliferating intestinal
epithelium. The intestinal hypertrophy was accompanied by
a substantial increase in numbers of Dl- and esg-expressing
cells (Figures 1I and 1J). esg-lacZ was no longer restricted to
adjacent pairs of cells (the ISCandEB) (Figures 2F; FigureS1M)
but instead was detected in many cells that morphologically
appear to be ECs (recognizable by their large size and large,
polyploid nucleus) (Figure 1I). We suggest that this reflects
both the accelerated proliferation and differentiation of pro-
genitor cells, as well as the stability of b-galactosidase. Confir-
mation that activation of endogenous Yki specifically within
ECs also increases Dl-expressing progenitor cells was pro-
vided by examination of intestines in which Wts was depleted
from ECs by TARGET-controlled induction of wts RNAi under
MyoIa-Gal4 control, which resulted in accumulation of small
Dl-expressing cells basal to the large, MyoIa-expressing ECs
(Figures 1K and 1L). These observations imply that Yki
Warts and Yorkie Mediate Intestinal Regeneration
1581activation in ECs exerts a strong, nonautonomous influence on
the proliferation of ISCs.
To directly visualize this increased proliferation, we stained
for cells in mitosis using anti-phospho-Ser10-Histone H3
(pH3) and labeled cells in S phase using EdU. When Yki was
activated specifically in ECs usingMyoIa-Gal4 to drive expres-
sion of YkiS168A:V5 or wts RNAi, then the number of cells
labeling for pH3 and EdU increased substantially (Figures
1M–1Q). pH3 staining was only detected in small, scattered
cells, which we infer are ISCs, based on their distribution and
morphology (Figure 1P). This implies that activation of Yki
does not cause the normally nonproliferating EBs, enteroen-
docrines (EEs), or ECs to proliferate, but rather increases the
proliferation rate of ISCs. ISC proliferation is normally very
low, and we detected an average of two pH3-staining mitoses
per adult posterior midgut in control animals, consistent with
prior studies (Figure 1Q) [9]. By contrast, wts-RNAi-treated
posterior midguts averaged 55 pH3-staining mitoses (Fig-
ure 1Q). EdU labeling was increased not only in ISCs but also
in ECs (Figures 1M–1P). ECs become polyploid through endor-
eplication; the increased DNA synthesis might reflect a more
rapid differentiation of ECs [9] and/or an increase in polyploidy,
which could enable the cells to grow larger.
To further characterize the nonautonomous influence of Yki
activation on ISC proliferation, we generated clones of cells
with activated Yki. Induction of YkiS168A:V5 expression in
clones using the Flp-out technique, which enables expression
to be induced in nondividing cells [26] and thus allows induc-
tion of expression directly in ECs, resulted in a rapid, nonau-
tonomous increase in esg-lacZ-expressing cells (Figure 2C).
Induction of clones by mitotic recombination is limited to
dividing cells, which means that such clones can only be
induced in the ISC. However, after waiting several days, these
clones can increase in size through subsequent divisions of
the ISC and can include ECs differentiated from EB daughter
cells within the clone. Mitotic recombination was coupled to
the MARCM technique to make clones of cells expressing
YkiS168A:V5 or mutant for wts. Both of these methods of Yki
activation also nonautonomously increased ISC proliferation,
based on examination of esg and Dl, as well as direct examina-
tion of proliferation using pH3 or EdU labeling (Figures 2;
Figure S2). Activation of Yki did not block differentiation,
because MARCM clones with activated Yki, which must have
been induced in dividing ISCs, could include cells with large
nuclei, which expressed Pdm1, a marker of differentiated
ECs (Figure S2E). Based on EdU labeling, pH3 staining, esg-
lacZ expression, or Dl expression, the range of the nonauton-
omous response to Yki activation in EC cells could extend for
several cells (Figure 2).
The nonautonomous influence of Yki activation on ISCprolif-
eration implies that activation of Yki in ECs leads to production
of a secreted signal that can influence ISC proliferation.
Several manipulations that can influence intestinal cell prolifer-
ation have been identified, including expression of Wg in
visceral muscle cells [24], mutation of Notch in ISCs [3, 4], acti-
vation of the Jnk pathway in ECs [6, 7, 9, 12], and activation of
the Jak-Stat pathway in ISCs [7, 9, 13, 14]. The Jak-Stat path-
way was a candidate effector of the influence of activated Yki,
because ligands for this pathway are expressed in ECs in
response to damage, infection, or activation of Jnk signaling,
and activation of the pathway within ISCs in response to
secreted Upd ligands promotes their proliferation [7, 9, 13,
14]. Additionally, like Wts and Yki, Jak-Stat and Jnk signaling
have rapid effects on ISC proliferation, visible in less than2 days, whereas manipulations of Wg or Notch signaling
require longer times for significant effects on proliferation to be
observed. Indeed, using an upd-lacZ reporter, we found that
upd was barely detected in control intestines but was readily
detected after activation of Yki in ECs (Figures 3A and 3B).
The upd locus includes three related genes, upd1 (os), upd2,
and upd3. To examine the expression of individual upd genes,
and to quantify their expression, we performed quantitative
reverse transcriptase-polymerase chain reaction on intestines
with activated Yki in ECs. Expression of upd3 increased
approximately 25-fold, whereas upd1 and upd2 increased 7-
to 8-fold (Figure 3L). This upregulation resulted in a visible
increase in Jak-Stat pathway activity, as monitored by expres-
sion of a Stat-DGFP reporter [27] (Figures 3C and 3D). Based
on cellular morphology, Stat-DGFP was upregulated most
strongly in ISCs and EBs, but it was also visibly upregulated
in other intestinal cells. These observations suggest that acti-
vation of Yki in ECs promotes ISC proliferation and intestinal
hyperplasia by inducing expression of upd genes, which are
secreted from ECs and then activate the Jak-Stat pathway in
ISCs and EBs to promote their proliferation and differentiation.
To test this hypothesis, we used RNAi to simultaneously
reduce expression ofwts and hopscotch (hop), which encodes
the Drosophila Jak kinase. Because wts is required in ECs,
whereas Jak-Stat signaling is required in ISCs, tub-Gal4 was
used to reduce the levels of both genes in both cell types.
The increases in Dl expression and pH3-staining cells normally
associated with wts RNAi were reduced by RNAi of hop
(Figures 3I–3K; Figure S3), whereas neutral upstream acti-
vating sequence (UAS) transgenes (i.e., UAS-GFP) did not
affect wts RNAi phenotypes. In a second approach, mitotic
recombination was used to make clones doubly mutant for
wts and stat92E, which encodes the DNA-binding transcrip-
tion factor of the Jak-Stat pathway. The influence of stat92E
on ISC proliferation in these experiments was assayed by
counting the number of cells within each clone. Clone size
was significantly reduced using either of two different stat92E
alleles (Figures 3E–3H). As expected, nonautonomous effects
of wts on ISC proliferation were not blocked (Figure 3F). Thus,
both experimental approaches confirm that the influence of
Yki activation on Jak-Stat signaling contributes to its effect
on ISC proliferation. The suppression was incomplete, which
might be due to residual Hop or Stat or to production of addi-
tional mitogens, acting via other pathways, induced by Yki
activation in ECs.
The observation that reducing wts levels increases ISC
proliferation indicates that Wts is normally active in ECs and
needs to be active there to prevent excess ISC proliferation.
In order to investigate whether Yki has a normal role in
promoting endogenous levels of ISC proliferation, we em-
ployed RNAi-mediated knockdown of yki in EC cells. Antibody
staining confirmed that RNAi reduced levels of Yki (Figure 4B;
data not shown). However, even after 7 to 10 days, the overall
size of the intestine and number of ISCs was similar or only
modestly reduced compared to that in control animals. This
suggests that endogenous levels of Yki are not required
for maintaining intestinal homeostasis in healthy animals,
although this is subject to the caveat that some residual Yki
was detected in RNAi-treated intestines.
Expression of upd genes is normally very low in intestinal
cells but is upregulated in response to damage or infection
to trigger a regenerative response that induces ISC prolifera-
tion [7, 9, 13, 14]. To investigate whether Yki has a role in
damage response, we treated animals with bleomycin, a
Figure 1. Yki and Wts Act in Enterocytes to Influence Intestinal Stem Cell Proliferation
(A) Schematic of cell types in the intestine. Intestinal stem cells (ISCs) divide (red arrows) asymmetrically to an enteroblast (EB) and an ISC. EBs then differ-
entiate (black arrows) into enterocytes (ECs) or enteroendocrines (EEs). Cell-type-specific markers are indicated in green.
(B–P) Portions of the adult posterior midgut stained for DNA (blue, using DAPI), esg (green, using esg-lacZ or esg-Gal4 and UAS-GFP), Arm (red), Actin
(green, using phalloidin), pH3 (green), EdU (red), or Dl (red/white), as indicated. Panels marked prime show individual channels of the stain to the left.
(B) Control (without Gal4) Tub-Gal80ts UAS-wts-RNAi after temperature-shift induction for 7 days.
(C) Tub-Gal80ts Tub-Gal4 UAS-dcr2 UAS-wts-RNAi after 7 days induction.
(D) esg-Gal4 tub-Gal80ts UAS-ykiS168A:V5 UAS-GFP, 10 days after induction.
(E) esg-Gal4 tub-Gal80ts UAS-GFP control, 10 days after induction.
(F and F0) MyoIa-Gal4 tub-Gal80ts esg-lacZ control, 2 days after induction.
(G) MyoIa-Gal4 tub-Gal80ts control, 2 days after induction; image shows an optical cross-section through the center of the intestine.
(H) MyoIa-Gal4 tub-Gal80ts UAS-ykiS168A:V5, 2 days after induction; image shows an optical cross-section through the center of the intestine.
(I and I0) MyoIa-Gal4 tub-Gal80ts UAS-ykiS168A:V5 esg-lacZ, 2 days after induction.
(J and J0) MyoIa-Gal4 tub-Gal80ts UAS-ykiS168A:V5, 5 days after induction.
(K–L0)MyoIa-Gal4 tub-Gal80ts UAS-GFP wts RNAi UAS-dcr2, 6 days after induction. (K) and (K0) show a projection through several horizontal sections. (L)
and (L0) show a vertical section; yellow arrows point to Dl-expressing cells basal to MyoIa-Gal4 expression.
(M and M0) MyoIa-Gal4 tub-Gal80ts control, 11 days after induction, stained and labeled for EdU.
(N and N0) MyoIa-Gal4UAS-dcr2 tub-Gal80ts control, 6 days after induction, stained and labeled for EdU and pH3.
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Figure 2. Nonautonomous Influence of Yki on ISC Proliferation
Portions of the adult posterior midgut stained for DNA (blue, using DAPI), esg (green, using esg-lacZ), pH3 (magenta), EdU (red), or Dl (red/white), as indi-
cated. Panels marked prime show separate channels of the stain to the left.
(A and A0) Tub-Gal4 MARCM control clones (marked by GFP, green), 7 days after induction.
(B and B0) Tub-Gal4 UAS-ykiS168A:V5 MARCM clones (marked by GFP, green), 7 days after induction.
(C) Tub-Gal4 UAS-ykiS168A:V5 Flp-out clones (marked by GFP, red), 2 days after induction; cf. Figure 1F.
(D–D00)wtsX1mutant clones (marked by expression of GFP, green), 8 days after clone induction, stained for DNA, Dl, and pH3. (D0) shows Dl expression rela-
tive to clones, (D00) shows pH3 staining relative to the clones. Regions devoid of clones (yellow asterisk) do not have elevated Dl or pH3 staining.
(E and E0) Tub-Gal4MARCM control clones, 10 days after induction, stained and labeled for EdU. Clones (marked by GFP, green) are small, and EdU labeling
(red) is rare. Arrow points to an example of an EdU-labeled nucleus.
(F and F0) Tub-Gal4 UAS-ykiS168A:V5 MARCM clones, 10 days after induction, stained and labeled for EdU. Clones (green) are larger. Regions devoid of
clones (yellow asterisk) do not have elevated EdU labeling.
See also Figure S2.
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1583DNA-damaging agent that induces a regenerative response in
the intestine [11]. The increase in Dl-expressing progenitors
associated with bleomycin treatment (Figure 4A) was reduced
by RNAi of yki (Figure 4B). The increase in ISC mitosis associ-
ated with bleomycin (visualized by pH3 staining) was also
reduced by yki RNAi, to about half the level in sibling controls
(Figures 4C–4E). These observations indicate that the
damage-response pathway activated by bleomycin acts at
least in part through Yki. Consistent with this, Yki localization
was altered in bleomycin-treated intestines. In wild-type, Yki
is predominantly cytoplasmic (Figure 4I) [19, 20], but in ECs
of bleomycin-treated intestines, increased Yki could be
detected within the nucleus of many cells (Figure 4H), which
is a hallmark of Yki activation [19, 20]. Additionally, a transcrip-
tional reporter of Hpo signaling, ex-lacZ [28], was upregulated(O and O0) MyoIa-Gal4 tub-Gal80ts UAS-ykiS168A:V5, 3 days after induction.
(P and P0)MyoIa-Gal4UAS-dcr2 wtsRNAi tub-Gal80ts, 6 days after induction, st
pH3-stained mitotic cells.
(Q) Quantitation of pH3-stained mitotic cells in posterior midguts of the indicate
Figure S1.(Figure 4G). Thus, a toxin that damages ECs can induce Yki
activation.
Analysis of intestinal regeneration and upd expression has
implied that there are multiple, parallel mechanisms by which
infection or tissue damage can upregulate upd genes [7, 9,
13]. Many of these act through the Jnk signaling pathway,
which mediates responses to tissue damage in diverse con-
texts, including toxins, aging, and infection. Direct activation
of Jnk signaling can also induce intestinal hyperplasia and
expression of upd genes [6, 7, 9, 12]. Thus, we investigated
whether Jnk is involved in mediating the effects of tissue
damage on Yki. Indeed, direct activation of Jnk signaling
in ECs, achieved by expression of an activated form of the
Jnk-kinase Hemipterous (Hep), HepCA, using MyoIa-Gal4 or
Gal4-expressing clones, increased nuclear Yki localizationained and labeled for EdU and pH3. White arrows point to some examples of
d genotypes; error bars indicate standard error of the mean (SEM). See also
Figure 3. Yki Regulates the Jak-Stat Pathway
Portions of the adult posterior midgut stained for DNA (blue, DAPI), upd-lacZ (red), Stat-DGFP (green), Dl (red), pH3 (green), or Arm (red), as indicated.
Experimental and control images were stained in parallel and captured with identical confocal settings.
(A and A0) MyoIa-Gal4 tub-Gal80ts UAS-ykiS168A:V5 upd-lacZ, 2 days after induction.
(B and B0) MyoIa-Gal4 tub-Gal80ts UAS-ykiS168A:V5 upd-lacZ control (maintained at 18C).
(C and C0) MyoIa-Gal4 tub-Gal80ts UAS-ykiS168A:V5 10X-Stat-DGFP, 1 day after induction.
(D and D0) MyoIa-Gal4 tub-Gal80ts UAS-ykiS168A:V5 10X-Stat-DGFP control (maintained at 18C).
(E–G) Examples of wtsX1 (E), wtsX1 stat92E06436 (F), and control MARCM clones (G), marked by expression of GFP, green, 8 days after clone induction,
stained for Dl.
(H) Quantitation of average clone size for clones of the indicated genotypes (WT = wild-type control), error bars show SEM.
(I–K) Examples of wts RNAi (I), hop RNAi (J), and hop; wts RNAi (K), 7 days after induction by temperature shift, stained and labeled for Dl and pH3.
(L) Fold change in RNA levels of upd genes by quantitative reverse transcriptase-polymerase chain reaction between MyoIa-Gal4 tub-Gal80ts
UAS-ykiS168A:V5 andMyoIa-Gal4 tub-Gal80ts (control), 1 day after temperature-shift induction, normalized to RpL32. Error bars indicate standard deviation.
See also Figure S3.
Current Biology Vol 20 No 17
1584(Figures 4J and 4K). Thus, Jnk activation can promote Yki acti-
vation. Consistent with Jnk acting upstramof Yki, we observed
that inhibition of Jnk signaling, achieved by expressing a domi-
nant-negative form of the Drosophila Jnk Basket (Bsk), BskDN,
which blocks Jnk pathway activation in the intestine [6, 9, 12],
did not block the influence of YkiS168A:V5 on ISC proliferation
(Figures S4A and S4B). We also note that, unlike Jnk pathway
activation, Yki activation did not induce visible apoptosis or
caspase cleavage (Figures S2C and S2D).Our results establish that two Hippo pathway components,
Wts and Yki, play a crucial role in a damage-response pathway
(Figure S4C). Activation of Yki promotes the expression of
cytokines that promote the proliferation and differentiation of
ISCs. Because Jnk signaling is generally activated by tissue
damage and infection, the discovery that Yki is activated by
Jnk signaling in the intestine raises the possibility that Hippo
signaling might play a general role in regenerative responses
to tissuedamage. This possibility also suggests a convergence
Figure 4. Yki Activity Is Regulated by Damage Response Pathways
Portions of the adult posterior midgut stained for DNA (blue, DAPI), Yki (green), Dl (red/white), pH3 (red), ex-lacZ (magenta), or Arm (red), as indicated.
(A and A0) Bleomycin treatment for 2 days increases Dl-expressing cells.
(B and B0) MyoIa-Gal4 tub-Gal80ts UAS-RNAi-yki UAS-dcr2 with induction of yki RNAi for 7 days, and bleomycin treatment for 2 days.
(C) Quantitation of pH3 mitoses per posterior midgut in animals treated and stained as in (D) and (E). Error bars indicate SEM.
(D) Bleomycin treatment for 2 days increases pH3-stained mitoses cells.
(E) MyoIa-Gal4 tub-Gal80ts UAS-RNAi-yki UAS-dcr2 with induction of yki RNAi for 10 days, and bleomycin treatment for 2 days, stained for pH3.
(F) ex-lacZ flies without bleomycin treatment.
(G) ex-lacZ flies with 2 days bleomycin treatment, stained and imaged under the same conditions as (F); quantitation of staining intensity identified a 2.4-fold
increase in ex-lacZ relative to controls.
(H and H0) Bleomycin treatment for 2 days results in partial translocation of Yki into the nucleus.
(I and I0) MyoIa-Gal4 tub-Gal80ts control flies without bleomycin treatment; Yki is cytoplasmic.
(J and J0) Flp-out tub-Gal4 UAS-hepCA clones; flies were kept at 18C for 5 days after clone induction and then shifted to 29C 24 hr before dissection.
Dashed line outlines a clone.
(K and K0) MyoIa-Gal4 tub-Gal80ts UAS-hepCA, 1 day after induction.
See also Figure S4.
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and the role of infection and tissue damage in oncogenesis
[30, 31].
Hippo signaling can have both autonomous and nonautono-
mous effects on growth [32, 33], and we report here that in the
adult Drosophila midgut, Yki has profound nonautonomouseffects on growth via the Jak-Stat pathway. Jak-Stat signaling
is important for proliferation control and stem cell biology, not
only in the Drosophila intestine, but also in other tissues, both
inDrosophila and in vertebrates [34–36]. Members of the inter-
leukin (IL) family of cytokines are homologous to Upd ligands,
and a microarray study in cultured mammalian cells found that
Current Biology Vol 20 No 17
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raises the possibility that a regulatory connection between
Hippo signaling and Jak-Stat signaling might be conserved.
Increased levels and nuclear localization of Yap have been
reported in colon cancer patient samples [16], and ubiquitous
Yap1 overexpression causes overproliferation of progenitor
cells in the murine intestine [15]. Our observations suggest
that future considerations of the potential contributions of
Hippo signaling to colon cancer should include evaluations
both of its possible regulation by Jnk signaling and of possible
nonautonomous effects mediated by cytokines.
Experimental Procedures
Drosophila Genetics
Conditional expression in adult flies using tub-Gal80ts was achieved by
maintaining flies at 18C throughout their development and then shifting
6- to 8-day-old (at 18C) adult females to a higher temperature for induction
of gene expression. Initial experiments employed a shift to 30C, but we
found later that a shift to 28.5C was also effective. For wts conditional
RNAi, Tub-Gal80ts/CyO; Tub-Gal4 UAS-dcr2/TM6b, MyoIA-Gal4/CyO;
Tub-Gal80ts UAS-dcr2/TM6b, or MyoIA-Gal4 Tubgal80ts UAS-GFP/CyO;
UAS-dcr2/TM6B flieswere crossed toUAS-wts-RNAi (vdrc9928). For condi-
tional Yki expression, esg-Gal4/CyO; Tub-Gal80ts/TM6b, esg-Gal4 UAS-
GFP UAS-n.lacZ/CyO; Tub-Gal80ts/TM6b, Tub-Gal80ts/(CyO); How-Gal4/
(TM6b), or MyoIA-Gal4/Cyo; Tub-Gal80ts/TM6b were crossed to esg-lacZ/
(CyO); UAS-yki168A:V5/(TM6b),UAS-nls:GFP/(CyO); UAS-yki168A:V5/(TM6b),
y w hs-FLP; 10XStat-DGFP (destabilized GFP) [27]/(CyO);UAS- yki168A:V5/
(TM6B), upd-lacZ;UAS- yki168A:V5/TM3, UAS-BskDN; UAS-yki168A:V5/TM3,
or y w hs-FLP; IF/CyO; UAS-HepCA/TM6b. For expression of activated Yki
or Hep in Flp-out clones, w tub>CD2>Gal4 UAS CD8:GFP/CyO; Tub-
Gal80ts/TM6b was crossed to y w hs-FLP; IF/CyO; UAS-yki168A:V5 or y w
hs-FLP; IF/CyO; UAS-HepCA/TM6b. Adult females were aged for 3–4 days
and heat shocked at 37C for 1 hr, then the vials were placed back to
18C for 5–12 days, and finally they were shifted to 30C for the desired
time and dissected. For expression of activated Yki in MARCM clones,
y+ FRT40A/CyO;UAS- yki168A:V5/(TM6B) was crossed to y w hs-FLP
Tub-Gal4 UAS-GFP/FM7; Tub-Gal80 FRT40A/CyO. For wts and stat92E
MARCM clones, y w hs-FLP Tub-Gal4 UAS-GFP; UAS-y+/(CyO); FRT82B
tub-gal80/TM6B was crossed to w; wtsX1 FRT82B/TM6B, w; stat92E85C9
FRT82B/TM6B, w; stat92E06346 FRT82B/TM6B, w; wtsX1 stat92E85C9
FRT82B/TM6B, or w; wtsX1 stat92E06346 FRT82B/TM6B. Six- to eight-day-
old (at 18C) adult females were then heat shocked at 37C for 35 min and
kept at 25C until dissection. For hop-RNAi, we used vdrc102830. A
substantial increase in esg+ cells was observed in a small fraction (approx-
imately 1/15) of intestines in both experimental and control animals. We
suspect that this sporadic phenotype reflects stimulation of ISC prolifera-
tion by ingested microbes [6–10, 13], and we focused only on phenotypes
that consistently correlated with experimental manipulations. As negative
controls, we used flies lacking the relevant UAS or Gal4 transgene, and
temperature shifted in parallel. In addition, we also performed control exper-
iments for all TARGET genotypes in which flies were not shifted to the
permissive temperature for expression.
Bleomycin Feeding Experiments
Bleomycin (Sigma) treatment was done as described previously [11] bymix-
ing bleomycin into instant food (final concentration 25 mg/mL) and feeding it
to flies cultured at 29C; flies were transferred daily into new vials with fresh
bleomycin. For RNAi experiments, MyoIA-Gal4/Cyo; Tub-Gal80ts/TM6b
was crossed to y w hs-FLP; UAS-yki RNAi (vdrc104523)/CyO; UAS-dcr2/
TM6b, and 3- to 4-day-old adult females were shifted to 29C for 5–8 days
before transferring to bleomycin at 29C for 2 more days.
Histology and Imaging
Posterior midguts of adult females were dissected in phosphate-buffered
saline, fixed in 4% paraformaldehyde for 45 min, and then stained with anti-
bodies, as described previously [32], using mouse anti-Arm (Developmental
Studies Hybridoma Bank [DSHB], 1:100), mouse anti-Dl (1:40, DSHB), goat
anti-b-gal (1:100, Biogenesis), rabbit anti-Yki (1:400) [20], rabbit anti-pH3
(1:500, Cell Signaling Technology), rabbit anti-Pdm1 (1:500, Y. Xiaohang),
rabbit anti-Cleaved Caspase-3 (1:200, Cell Signaling Technology), and
Alexa488-conjugated phalloidin (1:100, Invitrogen); secondary antibodieswere from Jackson ImmunoResearch. Confocal images were captured on
a Leica SP5, and images shown represent projections through a subset of
sections of a confocal stack.
Additional experimental procedures are in the Supplemental Experi-
mental Procedures.Supplemental Information
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at doi:10.1016/
j.cub.2010.07.041.
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